Endogenous tissue plasminogen activator in neonatal cerebrospinal fluid

European Journal of Pediatrics

Volumn 155, Issue 2, 1996, Pages 117-119

  Whitelaw, Andrew ^a   Mowinckel, Marie Christine ^b   Fellman, Vineta ^c   Abildgaard, Ulrich ^b  

^a AKER UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Cerebrospinal fluid; Hydrocephalus; Intraventricular haemorrhage; Newborn infant; Plasminogen activator

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

ARTICLE; BRAIN VENTRICLE HEMORRHAGE; CEREBROSPINAL FLUID LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FIBRINOLYSIS; GESTATIONAL AGE; HUMAN; INFANT; NEWBORN; PRIORITY JOURNAL;

EID: 0030052992     PISSN: 03406199     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02075763     Document Type: Article

References (19)

1. Brinker T, Seifert V, Dietz H (1992) Subacute hydrocephalus after experimental subarachnoid hemorrhage: its prevention by intrathecal fibrinolysis with recombinant tissue plasminogen activator. Neurosurgery 31: 306-312
2. Corrigan JJ, Jeter MA (1992) Tissue-type plasminogen activator, plasminogen activator inhibitor and histidine-rich glycoproteins in stressed human newborns. Pediatrics 89: 43-46
3. De Vries LS, Larroche JC, Levene MI (1988) Germinal matrix haemorrhage and intraventricular haemorrhage. In: Levene MI, Bennett M, Punt J (eds) Fetal and neonatal neurology and neurosurgery. Churchill Livingstone, Edinburgh, pp 312-325
4. Findlay JM, Weir B, Kassell NF, Disney LB, Grace MG (1991) Intracisternal recombinant tissue plasminogen activator after aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 181-188
5. Findlay JM, Weir BKA, Stollery DE (1991) Lysis of intraventricular hematonia with tissue plasminogen activator. J Neurosurg 74: 803-807
6. Hill A, Shackleford GD, Volpe JJ (1984) A potential mechanism of pathogenesis for early post-hemorrhagic hydrocephalus in the premature newborn. Pediatrics 73: 19-21
7. Larroche JC (1972) Posthaemorrhagic hydrocephalus in infancy. Biologia Neonatorum 20: 287-299
8. Levene MI (1981) Measurement of the growth of the lateral ventricles in preterm infants with real time ultrasound. Arch Dis Child 56: 900-904
9. Mizoi, K, Yoshimoto T, Takahashi A, Fujiwara S, Koshu K, Sugawara T (1993) Prospective study on the prevention of cerebral vasospasm by intrathecal fibrinolytic therapy with tissue-type plasminogen activator. J Neurosurg 78: 430-437
10. Neuman T, Stephens RW, Salonen EM, Tinmusk T, Vaheri A (1989) Induction of morphological differentiation of human neuroblastoma cells is accompanied by induction of tissue type plasminogen activator. J Neurosci Res 23: 274-281
11. Öhman J, Servo A, Heiskanen O (1991) Effect of intrathecal fibrinolytic therapy on clot lysis and vasospasm in patients with aneurysmal subarchnoid hemorrhage. J Neurosurg 75: 197-201
12. Pang D, Sclabassi RJ, Horton JA (1986) Lysis of intraventricular clot with urokinase in a canine model. 3. Effects of intraventricular urokinase on clot lysis and posthaemorrhagic hydrocephalus. Neurosurgery 19: 553-572
13. Pittman RN, Ivins JK, Buettner HM (1989) Neuronal plasminogen activator: cell surface binding sites and involvement in neurite outgrowth. J Neurosci 9: 4269-4286
14. Qian Z, Gilbert ME, Colicos MA, Kandel E, Kuhl D (1993) Tissue-plasminogen activator is induced as an immediate-early gene during seizure, kindling and long-term potentiation. Nature 361: 453-457
15. Stolke D, Seifert V (1992) Single intracisternal bolus of recombinant tissue plasminogen activator in patients with aneurysmal subarchnoid hemorrhage: preliminary assessment of efficacy and safety in an open clinical study. Neurosurgery 30: 877-881
16. Ventriculomegaly Trial Group (1990) Randomised trial of early tapping v conservative management in infants with post-haemorrhagic hydroeephalus. Arch Dis Child 65: 3-10
17. Whitelaw A (1993) Endogenous fibrinolysis in neonatal cerebrospinal fluid. Eur J Pediatr 152: 928-930
18. Whitelaw A, Creighton L, Gaffney P (1991) Fibrinolytic activity in CSF after intraventricular haemorrhage. Arch Dis Child 66: 808-809
19. Zabramski JM, Spetzler RF, Lee S, Papodopoulos S, Bovill E, Zimmerman RS, Bederson J (1991) Phase 1 trial of tissue plasminogen activator for the prevention of vasospasm in patients with aneurysmal subarachnoid hemorrhage. J Neurosurg 75: 189-196